Optimising Treatment
The consortium has published guidance on how to optimise and implement a synergistic medical and surgical treatment plan for perianal Crohn's disease. This involved the input of a large international panel of medical & surgical perianal disease experts.
Included in the guidance are:
When a fistula may be suitable for surgical repair - and how medications improving perianal inflammation can assist in promoting the best post-operative outcomes.
How medications & surgeries may be utilised for targeting both symptomatic improvements and fistula healing in pCD
How to optimise medications and manage them around the time of surgeries
How medical & surgical care can be coordinated to "downstage" fistula classification groups - i.e. simplifying a non-repairable fistula (2b) where possible into a repairable (2a) one.
Figure: A case of anatomical rationalization and fistula downstaging from Class 2b to 2a. (A), Active intersphincteric horseshoe extension at presentation; (B), Healed (fibrosed) horseshoe following intensive VAAFT; (C), Main fistula tract at presentation; (D), Main tract with reduced but ongoing activity following VAAFT; (E), Radiological healing (fibrosis) of main tract following definitive surgical repair.
Related Researchers
City: London | Country: United Kingdom
The Fistula Research Unit at St. Mark’s Hospital is headed by Professor Ailsa Hart and Mr Phil Tozer. The centre has a strong history of championing research in the field of perianal Crohn’s Disease and progressing the medical and surgical management of perianal fistula.
City: Chicago | Country: USA
Consortium description coming soon
City: Vancouver | Country: Canada
Astrid Williams has joined the team at the IBD centre of B in 2024. From 2018 to 2023, she was a Staff Specialist Gastroenterologist at Liverpool Hospital in Sydney, Australia.
City: Cambridge | Country: United Kingdom
Dr Nuru Noor is a Clinical Lecturer in Gastroenterology based at the University of Cambridge in the UK. He also works as an Honorary Postdoctoral Research Associate at the Medical Research Council Clinical Trials Unit
City: Abu Dhabi | Country: United Arab Emirates
Dr. Sara El Ouali is a consultant gastroenterologist at Cleveland Clinic Abu Dhabi (CCAD) and is an Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine in Cleveland, Ohio …
City: London | Country: United Kingdom
The Fistula Research Group at the University of Nottingham and Motilent is at the forefront of research in perianal Crohn’s disease and Inflammatory Bowel Disease.
City: Paris | Country: France
The Proctology Department at Hôpital Paris Saint-Joseph is a department specialising in the medical, instrumental and surgical treatment of diseases of the anus.
City: Ghent | Country: Belgium
The perianal fistulizing Crohn’s disease clinical and research program at The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at Mount Sinai is co-led by gastroenterologist Dr. Serre-Yu Wong and colorectal surgeon Dr Sergey Khaitov.
City: New York | Country: America
The perianal fistulizing Crohn’s disease clinical and research program at The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at Mount Sinai is co-led by gastroenterologist Dr. Serre-Yu Wong and colorectal surgeon Dr Sergey Khaitov.
City: Leuven | Country: Belgium
The perianal Fistula Research Program within the IBD referral centre of UZ/KU Leuven is coordinated by colorectal surgeons Gabriele Bislenghi and André D’Hoore and gastroenterologists Séverine Vermeire and Bram Verstockt.
City: Washington I Country: America
The Fistula Research Unit at St. Mark’s Hospital is headed by Professor Ailsa Hart and Mr Phil Tozer. The centre has a strong history of championing research in the field of perianal Crohn’s Disease and progressing the medical and surgical management of perianal fistula.
City: Melbourne | Country: Australia
The St Vincent's Hospital Melbourne Fistula Research Group is a passionate team of Australian researchers based in Melbourne, focused on expanding current and future research in the area of perianal fistulising Crohn’s disease. Our expert research team includes colorectal surgeon Dr. Cori Behrenbruch and Mr Michael Johnston, radiologist Dr. Leon Winata, gastroenterologists A/Prof John Ding and Dr. Michael De Gregorio, and research fellow Dr. Imogen Hartley and Dr Nicholas Clark.
City: San Diego | Country: United States
Led by Dr. Amy Lightner, a colorectal surgeon and Professor of Molecular and Cellular Biology and Professor of Immunology, the Lightner Lab at Scripps Research is dedicated to pioneering research in inflammatory bowel disease (IBD) and advancing novel treatment strategies for both complex luminal disease and perianal fistulizing disease…
City: Sāo Paulo | Country: Brazil
The IBD unit at the Santa Cruz Hospital, led by Prof. Dr. Natália Queiroz, is a recently established team, just three years old. Despite being a young unit, we are committed to providing multidisciplinary care with a patient-centered approach to treating IBD
Publications and Articles
A global TOpClass review and expert consensus outlining the small but significant risk of anorectal and fistula-associated cancers in long-standing perianal Crohn’s disease, with practical guidance on risk awareness and prompt investigation of new or changing perianal symptoms.